Ning Wang

Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors

Agnes L. Hipgrave Ederveen, J. Munkley, S. Moons, 2023, Glycobiology.

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells

J. Munkley, T. Boltje, Emiel Rossing, 2024, Cancers.

The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer

Abel Bermudez, Sharon J. Pitteri, Karen E. Livermore, 2023, Scientific reports.